VivaZome Therapeutics is delighted to announce that it has been awarded an Australian Government Round 13 CRC-P grant of $3.0m in support of the...
Read More »USPTO allows patent to exosome biomedical company Nurexone
The patent covers Nurexone’s ExoPTEN drug compositions and treatment methods for Central Nervous System disease NurExone Biologic Inc, a biopharmaceutical company developing biologically...
Read More »Capricor publishes new advances for its engineered exosome platform
StealthX™ Exosome Platform Shows Multivalent Vaccine Induces Long-Lasting Immunity to Multiple SARS-CoV-2 Proteins Capricor Therapeutics a biotechnology company focused on the development of transformative cell and exosome-based...
Read More »Burning Rock received FDA breakthrough device designation for its liquid biopsy OverC™ multi-cancer detection blood test
Burning Rock a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today announced that its OverC™ Multi-Cancer Detection Blood Test...
Read More »Sartorius collaborates with RoosterBio to advance downstream purification processes for the manufacture of exosomes
The life science group Sartorius extended a strategic collaboration partnership agreement with RoosterBio Inc. (RoosterBio) to address purification challenges and establish scalable downstream manufacturing...
Read More »Biological Dynamics Files Legal Action Against Co-founders of EXOKĒRYX
Arbitration filed against two former Biological Dynamics’ employees, vice presidents of core technology research and manufacturing...
Read More »US FDA grants breakthrough designation for blood test to help diagnose inaccessible brain tumors
The liquid biopsy has been developed by Datar Cancer Genetics to help diagnose brain tumors where a conventional biopsy is not possible...
Read More »MDimune details the development of their GMP manufacturing process for cell-derived vesicles in new publication
MDimune Inc, a Korean biotech company developing BioDrone™ platform technology based on cell-derived vesicles (CDVs), announced the publication of data in the Journal of Extracellular Biology showing...
Read More »Mantra Bio Raises $9 Million in Series A-2 Financing to Advance Development of Lead Targeted Exosome Therapeutics Program
Emerging Therapeutic Pipeline Focused on Ophthalmology and Infectious Disease Mantra Bio today announced it has raised $9 million in a Series A-2 financing to advance the development of its lead...
Read More »Exosome Research—Impeding into an Epoch of Bursting Development
A recent market report reveals the huge potential of exosome research, which is gaining mounting research fever across the industry. A recently published market report, “Exosome Research Market Share, Size, Trends, Industry Analysis Report, By Product (Kits and Reagents, Instruments, ...
Read More »